about
Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promisePotential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic ratsDiabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2.Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis.Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose.Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications.Endothelins in chronic diabetic complications.Growth factors in proliferative diabetic retinopathyC-peptide and retinal microangiopathy in diabetes.Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin.Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.Evolution of hemangioma endothelium.Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosisCurcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo.Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction.Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells.Differential effects of curcumin on vasoactive factors in the diabetic rat heart.Intrinsic regulation of hemangioma involution by platelet-derived growth factor.EDB fibronectin and angiogenesis -- a novel mechanistic pathway.Calcification of multipotent prostate tumor endothelium.Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications.Heme oxygenase in diabetes-induced oxidative stress in the heart.Oncofetal fibronectin in diabetic retinopathy.The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina.Heme-oxygenase-mediated iron accumulation in the liver.Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis.Endothelin-mediated remodeling in aortas of diabetic rats.Glucose-induced serum- and glucocorticoid-regulated kinase activation in oncofetal fibronectin expression.Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.Pro-oxidant role of heme oxygenase in mediating glucose-induced endothelial cell damage.2-amino-phenoxazine-3-one attenuates glucose-induced augmentation of embryonic form of myosin heavy chain, endothelin-1 and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells.Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction.Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells.ED-B fibronectin in non-small cell lung carcinoma.Glucose-induced regulation of novel iron transporters in vascular endothelial cell dysfunction.Elevated IGF2 prevents leptin induction and terminal adipocyte differentiation in hemangioma stem cells.In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells.
P50
Q27026834-C7AA9E39-2DD7-4DE9-B70C-5E93A35F3193Q28580273-1DCD02EF-937F-4F53-9EEC-EA11F3BEA579Q28583406-8D2F31C9-D86E-4B30-8C67-1143B077CEDAQ33606662-AE10BFC8-1331-4885-86DE-92619B77E80AQ33680355-6844C14D-A4E6-4104-BC5D-F68016507467Q34305712-CB9A088D-836D-41BA-9222-A104B13236C2Q35052800-3346083D-4203-4128-BE33-D6CA9E828891Q35168430-2A0BD655-F17B-4D1E-9420-3C8B330135E7Q35605154-6FD70A31-A0E1-4E11-A313-436F2635A11EQ35805841-A76EEDB3-1C5D-49C7-9024-26C76C6924EDQ35849864-9DB426A0-750B-4A1B-A226-3F2D920FD5FEQ35998796-5E71DC34-B137-4E69-8711-C95CFAFC2CB9Q36338963-D2073EE8-1AF7-4E5F-B384-B129593B9D27Q38008140-01046219-ADD2-4E7E-96BE-4875AFD2E699Q38260045-7EB578B2-A328-4C48-AB30-067893BC7DF6Q38936091-845FBEE0-CAA3-45C2-9498-AECC13AC353EQ39194260-AB074CE6-AD6D-4701-A72E-9AC053D3A5C9Q42041659-4946DC8B-CEBC-494C-A55D-DFB3FE0B61F0Q42075250-62C46EBA-297E-4514-A89B-9E48003102F7Q42222851-A1834472-C623-45C2-BCC3-9F42F59DC394Q42486951-305A439C-8A8A-48D6-98FB-953DC15A7770Q43226908-954B2E5E-7386-402D-8511-AE0218665999Q44312293-E44CD909-E0EE-4A67-8D35-8D4C13087EFDQ44679145-EED04112-9621-4A63-BF72-80B7F5720D94Q44703286-3036DE18-A031-4EDE-AAA2-73217737F0A7Q44737951-519C8DA8-AC4E-4751-8792-40D84FDF29B4Q45076007-7C448093-3100-40E2-8C01-7514C9D9BAC8Q45078376-B345B9AC-0B39-4ED2-BEB7-9923313F614AQ45174420-785D5258-2D73-46EA-BF9A-881875EC15D3Q45274345-DDAFA323-879B-435A-B2CB-3F822A4F133EQ46096844-88DE8FF8-5A7D-4448-8697-BE2B63E2470DQ46374490-F79B8F55-2DF6-4A6A-A311-9BB059735DFFQ46466091-2BD8DDAC-040E-49E9-85E7-729FC4360B20Q46509014-E3B9FF54-5F86-4B46-88E3-BC59F27BBB18Q46727455-62437860-0FC0-42CA-AC53-DCC4B91FD40DQ46734925-14DA5E0A-10B5-47DE-8E40-1DE6B445F51FQ46812982-1784AAA4-3087-4CBB-97EC-20490DF49711Q50554265-36A4C5F4-8857-4BD4-895A-3B6FE5087544Q51059546-03195D92-58E0-412F-A18F-9A2C12E81345Q54283805-5DF9B9C4-CEDE-48E8-8264-4DB37C7B7CA1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zia A Khan
@ast
Zia A Khan
@en
Zia A Khan
@es
Zia A Khan
@nl
Zia A Khan
@sl
type
label
Zia A Khan
@ast
Zia A Khan
@en
Zia A Khan
@es
Zia A Khan
@nl
Zia A Khan
@sl
prefLabel
Zia A Khan
@ast
Zia A Khan
@en
Zia A Khan
@es
Zia A Khan
@nl
Zia A Khan
@sl
P1053
G-8348-2011
P106
P31
P3829
P496
0000-0003-1682-5720
P569
2000-01-01T00:00:00Z